Figure 1.
Figure 1. Treatment with 50nM Aza and/or sequential MGC at 500 nM induces de nono expression of MAGE-A3 protein in the myeloma a cell line transfectant LP1 A68.

Treatment with 50nM Aza and/or sequential MGC at 500 nM induces de nono expression of MAGE-A3 protein in the myeloma a cell line transfectant LP1 A68.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal